Primary Listings

Covid Act Now Model and State Trends – Georgetown, Stanford Editor's Pick

A model by Covid Act Now, supported by Georgetown and Stanford universities, provides trends on infection rates, contact tracing and hospital capacity for each state. In addition to showing the how fast the COVID infection is spreading, it shows the positive test rate, and the percent of contacts who are traced. It also shows how close the hospitals in that area are to being maxed out. In each state, there are likely some county-specific data to help understand the direction of their forecast. Easy to read.

CDC Advisory Committee on Immunization Practices (ACIP) Recommendations on COVID-19 Vaccines (MMWR)

Read the Interim Recommendations on COVID-19 vaccines, from CDC’s Advisory Committee on Immunization Practices (ACIP). The Pfizer-BioNTech vaccine is outlined in the December 13, 2020 MMWR, after the FDA granted Emergency Use Authorization (EUA) on Dec. 11. The Moderna vaccine is outlined in the Dec. 20, 2020 MMWR. The Johnson & Johnson (Janssen) vaccine is outlined in the March 2, 2021 MMWR. While the MMWR is geared to medical professionals, much of it is understandable to the general public. The recommendations explain what meetings, experts and evidence were involved in ACIP’s work. Find who should get the vaccines in Phase 1a, Phase 1b and Phase 1c, as published Dec. 22 and Dec. 3. Priority groups for the first set of shots include healthcare workers and long-term care (LTC) residents. LTC includes skilled nursing facilities, nursing homes and assisted living. The CDC recommends that every person get the EUA Fact Sheet BEFORE vaccination. Recommendations will be updated as more information and clinical evidence become available.

CDC Vaccine Doses Delivered vs Received (shots in the arm), COVID-19

CDC reports the overall Covid-19 vaccine doses that are actually administered (shots in the arm) or received by people, compared to the number of doses delivered. As of the morning of Apr. 22, 2021, the percent of delivered/distributed doses that had been given as shots in the arm, was 78%: 219 million of 282 million doses. Doses administered Wednesday were 3 million. So far, 136 million people have gotten at least one shot; 89M people are reported as receiving both doses. For the week ending April 17, 3.2 million doses were administered on average per day, about 2% more than the prior week. However, shots given (22M for the week) were less than supply deliveries (27M). Long-term care vaccines administered to date were 7.8 million. Nearly five (4.9) million in LTC have received at least the first dose. Over 60 million doses are “un-administered”; i.e. still on the shelf. Just 45% of J&J delivered vaccine supply have been given as shots in the arm, with further J&J doses on pause. However, most of the un-administered doses are of Moderna and Pfizer vaccines.

Nearly all states have opened up vaccinations to all ages 16 and up. As of April 19, all states are expected to make vaccines available to all adults. Moderna, Pfizer BioNTech, and the new Johnson & Johnson COVID-19 vaccines are counted. Both vaccine and ancillary kits (syringes, etc.) are shipped. UPS, FedEx and McKesson are the national distributors. Although early vaccination rollout was slower than expected, it has gained speed. Instead of the 1 million doses per day (vaccinations) expected in December, that cumulative milestone was reached two months later, on March 1.

Clinical Trials for Coronavirus, NIH Editor's Pick

Find the latest update on clinical trials for vaccines and drugs that might be able to treat COVID-19 caused by the coronavirus. This official site is from NIH (National Institutes of Health) National Library of Medicine. As of January 7, 2021, an amazing number of studies – nearly 4,400 – were listed. Of those, 611 studies have been completed (including 79 in the US); another 143 have been terminated, suspended or withdrawn. While 1,250 studies were not yet recruiting participants, almost 2,400 were recruiting or enrolling subjects by invitation. The speed since the pandemic was declared March 11, is quite impressive. A recent search for COVID vaccine showed over 350 studies, 78 of which were in the United States. Short summaries available for each study may give an idea of how long the study will continue, and show if it was completed (with or without results posted). There are still 19 hydroxychloroquine studies actively recruiting or enrolling participants in the US.

FDA Updates on Coronavirus Disease COVID-19

The FDA, the federal Food and Drug Agency, provides updates on COVID-19 disease caused by the coronavirus. The FDA regulates lab testing, drugs requiring approval, medical devices (like N95s and other personal protective equipment PPE) and vaccines. They post regular updates, sometimes multiple times per day. In addition, the FDA has listed a few of the likely many fraudulent products with claims to prevent, treat, mitigate, diagnose or cure coronavirus disease.

Vaccines for COVID-19 – Operation Warp Speed

Find information on vaccines for COVID-19, from MedlinePlus. This ad-free website stays up to date on Operation Warp Speed – whose goal is to produce and deliver 300 million doses of safe and effective vaccines. The initial doses are now available to priority individuals. Find out how to volunteer to be one of the people in a clinical trial for COVID-19 vaccines; see “Coronavirus Clinical Studies”. Learn about vaccine safety. As vaccines receive emergency use authorization (EUA), this site reports it. Good site. However, the Operation Warp Speed website could be improved by more closely reporting the federal government plan (through at least 50 states) to get people vaccinated, not just manufacturing the vaccine.

Other Helpful Listings

Axios-Ipsos Weekly Views about Coronavirus (February 2021 update)

New Axios-Ipsos weekly poll (Wave 38) conducted February 5-8, 2021, still finds six in 10 people saying they are at least somewhat likely to get the Covid vaccine as soon as it’s available. Eight in 10 people are at least somewhat concerned about new strains of the virus that might be more transmissible or dangerous. As to rollout, expectations were not reported this week. In the early January wave, most people (55%) thought it was not very likely that 100 million people will be vaccinated by late April. Only 1/4 (27%) expect to return to normal either already, or within 6 months.

People continue to report wearing a mask, with 91% report wearing a mask all or sometimes when leaving their home; 73% said “at all times”. Maintaining a 6-foot distance from other people “at all times” is noticeably lower, at 54%. While over 1/3 of Americans (37%) visited friends or relatives in the last week, two-thirds perceived attending in-person gatherings of friends and family outside their own households as being a large or moderate risk. A month ago, 75% saw in-person gatherings as a risk. More than 3/4 said they stayed home last week as much as possible.

The CDC is still well regarded; about 2/3 trust CDC information on Covid and the coronavirus. Trust in state government information on Covid has declined to 54%, but still is higher than information from the “federal government”. Just over half (53%) had a great deal or fair amount of trust in Joe Biden. Generally, people trusted Covid information from their family and friends (58%), more than they trusted cable or online news (36 to 38%), or network news (47%).

Finally, 80% know someone who has tested positive for coronavirus, compared to about 2/3 at Thanksgiving. About 1/3 of people reported personally knowing someone who died from the disease.

The latest Coronavirus Index poll is Wave 38 of near-weekly surveys conducted by Axios-Ipsos. The current poll has a margin of sampling error of 3.4 percentage points. The poll was taken about two weeks after President Biden was inaugurated.

COVID-19 Vaccine Survey: December 2020 (KFF) Editor's Pick

A new survey finds 71% of people will “definitely” or “probably” get the COVID-19 vaccine. Survey was conducted by KFF (Kaiser Family Foundation) the first week of December 2020. A number of groups, however, are hesitant: Republicans, people ages 30-49, rural residents, and Black adults. The most common concern is possible side effects. More than half (53%) of those reluctant to get the vaccine wanted to “wait and see” how it works for other people first; for hesitant Black adults, 71% were taking a wait-and-see approach. Republicans’ top two reasons for being hesitant to get the vaccine were “The risks of COVID-19 are being exaggerated”, and they “do not trust the government to make sure the vaccine is safe and effective.” Furthermore, 71% of Republicans saw vaccination as a personal choice rather than part of everyone’s responsibility” to protect health. Generally, among people who said they would “definitely not” get the vaccine, fewer than half of wear a face mask consistently in public; two-thirds had one or more misconceptions about mask-wearing. All groups tended to trust their own doctor (85% overall) for reliable information about the vaccine. More than 3/4 of Republicans (78%) also trust President Trump a great deal or fair amount to provide reliable COVID-19 vaccine information.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search